The Cooper Companies, Inc. is a prominent player in the healthcare sector focusing on contact lenses and women's healthcare products. With a strong global presence, the company demonstrates stability in its operations. This analysis dives into its fundamental ratings and market expectations.
The Cooper Companies, Inc. holds a stable position with a fundamental rating of B, showing strength in equity returns and asset utilization but with room for improvement in valuation metrics.
Category | Score | Visualization |
---|---|---|
Discounted Cash Flow | 3 | |
Return On Equity | 4 | |
Return On Assets | 4 | |
Debt To Equity | 2 | |
Price To Earnings | 1 | |
Price To Book | 2 |
Tracking the historical scores shows consistent financial metrics over time, implying stable ongoing performance by the company.
Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
---|---|---|---|---|---|---|---|
2025-05-23 | 3 | 3 | 4 | 4 | 2 | 1 | 2 |
Previous | 3 | 3 | 4 | 4 | 2 | 1 | 2 |
Analysts provide a positive outlook with a consensus Buy rating, indicating expectations of potential price appreciation.
High | Low | Median | Consensus |
---|---|---|---|
107 | 105 | 106 | 106 |
Responsive stock chart image of The Cooper Companies, Inc.
The majority of analysts have issued Buy ratings, reflecting confidence in the company's future performance.
Recommendation | Count | Visualization |
---|---|---|
Strong Buy | 0 | |
Buy | 16 | |
Hold | 4 | |
Sell | 1 | |
Strong Sell | 0 |
The Cooper Companies, Inc. presents a balanced risk-reward profile with a strong foothold in the healthcare market. While there is solid operational efficiency, reflected in ROE and ROA, valuation metrics suggest room for growth. Analysts are optimistic about its future, which is reflected in the price targets and sentiment. Investors should weigh the potential for price fluctuations with the company's stability and market dynamics.